圣诺医药-B(02257.HK)部分完成发行100.37万股新股

Core Viewpoint - The company has partially completed the subscription agreement B on December 7, 2025, issuing 1,003,700 new shares at a price of HKD 12.00 per share to subscriber B [1] Group 1 - The company and subscriber B have mutually agreed to terminate the subscription of the remaining 2,151,286 shares [1] - Following the termination, all rights and obligations of the parties under subscription agreement B will become void, and neither party can make any claims against the other [1] - The board of directors believes that the termination of the remaining shares will not have any significant adverse impact on the company's existing business, operations, or financial condition [1]